Phathom Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PHAT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
15 Jul 24	SellUS$396,699	Terrie Curran	Individual	33,848	US$11.72
15 Jul 24	SellUS$50,689	Molly Henderson	Individual	4,325	US$11.72
15 Jul 24	SellUS$127,760	Azmi Nabulsi	Individual	10,901	US$11.72
09 Apr 24	SellUS$4,029,196	Takeda Pharmaceutical Company Limited	Company	362,737	US$11.94
08 Apr 24	SellUS$38,129	Molly Henderson	Individual	3,435	US$11.10
28 Mar 24	SellUS$6,435,841	Takeda Pharmaceutical Company Limited	Company	602,366	US$10.89
22 Mar 24	SellUS$153,513	Terrie Curran	Individual	16,851	US$9.11
24 Jan 24	SellUS$29,999,994	Takeda Pharmaceutical Company Limited	Company	3,703,703	US$8.10
19 Jan 24	SellUS$48,900	Molly Henderson	Individual	6,307	US$7.75
20 Nov 23	SellUS$15,403	Molly Henderson	Individual	2,127	US$7.24

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.4%.

Top 25 shareholders own 96.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	Frazier Life Sciences Management, LP	10,109,279	US$88.8m	0%	3.57%
10.9%	Medicxi Ventures (UK) LLP	7,464,572	US$65.5m	0%	13.51%
10.2%	Jennison Associates LLC	6,993,422	US$61.4m	19.2%	0.04%
5.59%	Invesco Ltd.	3,820,003	US$33.5m	21.6%	0.01%
5.11%	Abingworth LLP	3,496,808	US$30.7m	0%	21.31%
4.57%	BlackRock, Inc.	3,122,570	US$27.4m	6.7%	no data
4.08%	Takeda Pharmaceutical Company Limited	2,790,480	US$24.5m	0%	no data
3.94%	The Vanguard Group, Inc.	2,696,323	US$23.7m	21.9%	no data
3.78%	Ensign Peak Advisors, Inc.	2,581,388	US$22.7m	15%	0.04%
3.76%	Woodline Partners LP	2,573,412	US$22.6m	227%	0.19%
2.87%	New Enterprise Associates, Inc.	1,960,169	US$17.2m	0%	0.79%
2.64%	Avidity Partners Management, L.P.	1,804,493	US$15.8m	11.4%	0.88%
2.49%	Portolan Capital Management, LLC	1,699,918	US$14.9m	50.4%	1.05%
2.37%	Gilder Gagnon Howe & Co. LLC	1,622,883	US$14.2m	10.2%	0.16%
2.2%	Checkpoint Capital, LLC, Asset Management Arm	1,504,307	US$13.2m	71.9%	6.9%
2.12%	OrbiMed Advisors LLC	1,449,073	US$12.7m	0%	0.18%
2.05%	Federated Hermes, Inc.	1,403,638	US$12.3m	0%	0.03%
1.91%	FMR LLC	1,304,114	US$11.5m	49,000%	no data
1.83%	Decheng Capital LLC	1,250,000	US$11.0m	47.1%	2.31%
1.82%	Strategic Advisers LLC	1,243,191	US$10.9m	28.9%	no data
1.79%	David Socks	1,220,756	US$10.7m	0%	no data
1.65%	GW&K Investment Management, LLC	1,126,083	US$9.9m	87.5%	0.08%
1.64%	Catalys Pacific	1,122,572	US$9.9m	55.5%	9.0%
1.48%	683 Capital Management, LLC	1,010,000	US$8.9m	-27.9%	0.89%
1.35%	State Street Global Advisors, Inc.	922,788	US$8.1m	17.5%	no data